:: Volume 19, Issue 4 (10-2021) ::
Int J Radiat Res 2021, 19(4): 879-889 Back to browse issues page
Efficiency of modulated and dose rate altered flattening filter free beams in high dose per fraction radiotherapy applications on the survival of prostate cancer cell lines
C. Ceylan , A. Öztürk, G. Güngör, A.U. Karabey, S. Şahin, G. Duruksu, Y. Yazır, G. Aksu, Ö. Gündoğdu
Center for Stem Cell and Gene Therapies Research and Practice, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey , cemile.ceylan@istanbulonko.com
Abstract:   (608 Views)
Background: The radiobiological effect of high dose rate FFF beams on the DU-145 cells was investigated with SBRT plans which have >10 Gy. Methods and Materials: To compare the radiobiological effect on DU-145 cell line four experiments designed: (1) the constant dose rate of 6 MV and 6 MV FFF with increased dose per pulse (2) the effect of dose per pulse while increasing instantaneous dose rate for 6 MV and 6 MV FFF, (3) the effect of increased average dose rate for 6 MV FFF and (4) the effect of protracted treatment time and modulation of 6 MV FFF beams. The survival fraction was counted with WST. Results: FF and FFF for 6 MV with same dose rate and treatment time has no effect on cell survival. Significant differences was observed on survival which were irradiated with 6 MV 600 MU/min and 6 MV FFF 1400 MU/min (p=0.024). There was no difference between 6 MV FFF 600 MU/min and 6 MV FFF 1400 MU/min for 10 Gy. The significant survival difference obtained for 20 Gy. The survival percentages for both 10 Gy and 20 Gy with Cyberknife were obtained higher than FFF. Conclusion: Our in-vitro study presented here show that higher dose rate and reduced treatment time might become a crucial factor for SBRT especially which has >10 Gy fraction dose.
Keywords: Flattening filter free, Cell survival, Radiosurgery, Radiobiology
Full-Text [PDF 2103 kb]   (304 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology

XML     Print

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 19, Issue 4 (10-2021) Back to browse issues page